BOSTON, Feb. 3 /PRNewswire/ -- The 4th Annual “Psychiatric Disorders” conference, part of the CNS Diseases Congress, will focus on recent advances in schizophrenia, depression, anxiety, bipolar, sleep and related neurodegenerative disorders is scheduled to take place March 27-28, 2006 in Boston, MA, announces Strategic Research Institute.
The 2 day event will feature presentations from a variety of pharmaceutical, biotech, and academic leaders engaged in cutting edge work in the CNS field from early discovery through clinical development. Companies such as AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, Hoffmann-La Roche, Johnson & Johnson, Merck, Pfizer, Wyeth Research, Forest Laboratories, GlaxoSmithKline, Cephalon, Organon, DOV Pharmaceuticals and others will be in attendance.
The CNS Diseases Congress is organized into 3 concurrent tracks which feature 3 annual events on Psychiatric Disorders, CNS Clinical Development and Alzheimer’s Disease. The agenda will feature over 45 presentations in two days which includes a senior management executive plenary session on day one and academic keynote presentations on day 2.
To receive a copy of the agenda, please contact Glenn Pascual at gpascual@srinstitute.com or call 212.967.0095, ext 245. Please include your name, title, company, and mailing address.
To become a conference sponsor or exhibitor, please contact Jon Liong at jliong@srinstitute.com.
To inquire on how to become a media partner, please contact Cheryl Kahan- Radhuber at ckahan-radhuber@srinstitute.com.
Contact: Glenn A. Pascual Conference Producer, Life Sciences Strategic Research Institute 333 Seventh Avenue, 9th Floor New York, NY 10001-5004 Tel: 212.967.0095, ext. 245 Fax: 212.967.7973 Email: gpascual@srinstitute.com Website: http://www.srinstitute.com
Strategic Research Institute
CONTACT: Glenn A. Pascual, Conference Producer, Life Sciences of StrategicResearch Institute, +1-212-967-0095, ext. 245, fax: +1-212-967-7973,gpascual@srinstitute.com
Web site: http://www.srinstitute.com/
